Exposure to diacetyl volatiles in the fly model of Huntington’s disease reduces cell degeneration, as has been previously observed with orally administered HDAC inhibitors like sodium butyrate and SAHA in this genetic model (Steffan et al., 2001). Here, HDAC9 is linked to juvenile Huntington disease.